Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China
· Delayed Price · Currency is CNY 9.15
-0.30 (-3.17%)
Jun 13, 2025, 2:45 PM CST
SHA:603229 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,604 | 8,295 | 7,834 | 9,564 | 10,451 | 8,765 | Upgrade
|
| Market Cap Growth | 13.82% | 5.87% | -18.09% | -8.49% | 19.25% | 170.38% | Upgrade
|
| Enterprise Value | 6,785 | 7,572 | 7,115 | 9,183 | 9,848 | 8,455 | Upgrade
|
| Last Close Price | 9.18 | 9.99 | 9.32 | 11.93 | 13.01 | 10.89 | Upgrade
|
| PE Ratio | 36.08 | 40.11 | 30.86 | 40.64 | 71.62 | 100.93 | Upgrade
|
| Forward PE | - | 25.95 | 22.58 | 34.87 | 54.34 | 11.21 | Upgrade
|
| PS Ratio | 9.49 | 10.43 | 9.59 | 12.51 | 18.35 | 21.42 | Upgrade
|
| PB Ratio | 3.21 | 3.65 | 3.66 | 6.55 | 8.33 | 7.78 | Upgrade
|
| P/TBV Ratio | 3.43 | 3.92 | 3.94 | 7.36 | 9.58 | 8.35 | Upgrade
|
| P/FCF Ratio | 270.11 | 124.50 | 134.20 | - | - | 192.56 | Upgrade
|
| P/OCF Ratio | 49.70 | 46.62 | 35.32 | 79.33 | 60.10 | 63.30 | Upgrade
|
| EV/Sales Ratio | 8.47 | 9.52 | 8.71 | 12.01 | 17.29 | 20.66 | Upgrade
|
| EV/EBITDA Ratio | 26.68 | 30.50 | 24.96 | 38.32 | 54.04 | 62.95 | Upgrade
|
| EV/EBIT Ratio | 36.62 | 40.78 | 29.10 | 44.75 | 64.70 | 77.65 | Upgrade
|
| EV/FCF Ratio | 241.03 | 113.66 | 121.89 | - | - | 185.75 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.12 | 0.14 | 0.17 | 0.09 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 1.14 | 1.09 | 1.06 | 1.01 | 0.60 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 10.34 | 4.09 | 5.19 | - | - | 0.90 | Upgrade
|
| Asset Turnover | - | 0.27 | 0.31 | 0.37 | 0.35 | 0.36 | Upgrade
|
| Inventory Turnover | - | 0.98 | 1.09 | 1.32 | 1.21 | 0.97 | Upgrade
|
| Quick Ratio | 2.02 | 1.92 | 1.63 | 1.01 | 1.40 | 3.22 | Upgrade
|
| Current Ratio | 2.57 | 2.53 | 2.17 | 1.53 | 1.92 | 4.02 | Upgrade
|
| Return on Equity (ROE) | 9.46% | 9.37% | 14.09% | 17.33% | 12.25% | 9.80% | Upgrade
|
| Return on Assets (ROA) | - | 3.91% | 5.80% | 6.17% | 5.91% | 6.00% | Upgrade
|
| Return on Capital (ROIC) | 4.53% | 4.65% | 7.37% | 8.36% | 7.51% | 7.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.70% | 8.00% | 11.20% | 13.10% | 11.60% | 9.60% | Upgrade
|
| Earnings Yield | 2.81% | 2.49% | 3.24% | 2.46% | 1.40% | 0.99% | Upgrade
|
| FCF Yield | 0.37% | 0.80% | 0.74% | -1.58% | -1.31% | 0.52% | Upgrade
|
| Dividend Yield | 1.06% | 1.00% | 0.99% | 0.48% | 0.29% | 0.21% | Upgrade
|
| Payout Ratio | 39.50% | 40.73% | 22.63% | 16.00% | 13.69% | 15.43% | Upgrade
|
| Buyback Yield / Dilution | -3.45% | -0.99% | -1.92% | -1.16% | -6.67% | -0.25% | Upgrade
|
| Total Shareholder Return | -2.38% | 0.01% | -0.93% | -0.68% | -6.38% | -0.04% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.